黄浩佳,胡海波

• 1:国家心血管病中心北京协和医学院中国医学科学院阜外医院结构性心脏病中心

摘要(Abstract)：

术后残余右向左分流（rRLS）是影响卵圆孔未闭（PFO）介入治疗疗效的常见并发症之一，是远期再发性卒中或短暂性脑缺血发作的独立危险因素。传统外科手术修补是常规处理rRLS方法，但创伤比较大。本文介绍了1例采用Amplatzer ADOⅡ封堵器介入治疗PFO封堵术后rRLS伴明显偏头痛加剧的成功病例，为PFO封堵术后rRLS的处理提供了新的思路和策略。

关键词(KeyWords)： 卵圆孔未闭;残余漏;介入封堵

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 黄浩佳,胡海波

参考文献(References)：

• [1] Sndergaard L, Kasner S, Rhodes J, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J].N Engl J Med, 2017, 377(11):1033-1042.
• [2] Mas J, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med, 2017, 377(11):1011-1021.
• [3] Lee P, Song JK, Kim JS, et al. Cryptogenic stroke and highrisk patent foramen ovale:the DEFENSE-PFO trial[J]. J Am Coll Cardiol, 2018, 71(20):2335-2342.
• [4] Saver J, Carroll J, Thaler D, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J].N Engl J Med, 2017, 377(11):1022-1032.
• [5] Kasner S, Rhodes J, Andersen G, et al. Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke[J].N Engl J Med,2021,384(10):970-971.
• [6]黄浩佳.经导管卵圆孔未闭封堵术后残余分流影响因素及研究现状分析[J].心血管病学进展，2017,38(3):243-246.
• [7] Furlan A, Reisman M, Massaro J,et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale[J]. N Engl J Med, 2012, 366(11):991-999.
• [8] Meier B, Kalesan B, Mattle H, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism[J]. N Engl J Med, 2013, 368(12):1083-1091.
• [9] Carroll J, Saver J, Thaler D, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke[J]. N Engl J Med, 2013, 368(12):1092-1100.
• [10] Deng W, Yin S, Mcmullin D, et al. Residual shunt after patent foramen ovale closure and long-term stroke recurrence[J]. Ann Intern Med, 2020, 173(11):946-947.
• [11] Rovera C, Biasco L, Orzan F, et al. Percutaneous implantation of a second device in patients with residual rightto-left shunt after patent foramen ovale closure[J]. J Interv Cardiol, 2015, 27(6):548-554.
• [12] Susuri N, Obeid S, Ulmi M, et al. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale[J]. EuroIntervention, 2017, 13(7):858-866.
• [13] Moon J, Kang W, Kim S,et al. Comparison of outcomes after device closure with transseptal puncture and standard technique in patients with patent foramen ovale and ischemic events[J]. J Interv Cardiol, 2016, 29(4):400-405.
• [14] Kishve P, Motwani R. Morphometric study of fossa ovale in human cadaveric hearts:embryological and clinical relevance[J]. Anat Cell Biol, 2021, 54(1):42-50.
• [15] Mckenzie JA, Edwards WD, Hagler DJ. Anatomy of the patent foramen ovale for the interventionalist[J]. Catheter Cardiovasc Interv, 2009, 73(6):821-826.